These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 32256707

  • 1. Association between P2RY12 Gene Polymorphisms and IVIG Resistance in Kawasaki Patients.
    Wang Z, Xu Y, Zhou H, Wang Y, Li W, Lu Z, Jiang Z, Gu X, Zheng H, Zeng L, Huang P, Zhang L, Gu X.
    Cardiovasc Ther; 2020; 2020():3568608. PubMed ID: 32256707
    [Abstract] [Full Text] [Related]

  • 2. P2RY12:rs7637803 TT variant genotype increases coronary artery aneurysm risk in Kawasaki disease in a southern Chinese population.
    Lu Z, Xu Y, Fu L, Tan Y, Che D, Huang P, Pi L, Zhou H, Liang X, Zhang L, Gu X.
    J Gene Med; 2019 Jan; 21(1):e3066. PubMed ID: 30576025
    [Abstract] [Full Text] [Related]

  • 3. A low-frequency IL4R locus variant in Japanese patients with intravenous immunoglobulin therapy-unresponsive Kawasaki disease.
    Amano Y, Akazawa Y, Yasuda J, Yoshino K, Kojima K, Kobayashi N, Matsuzaki S, Nagasaki M, Kawai Y, Minegishi N, Ishida N, Motoki N, Hachiya A, Nakazawa Y, Yamamoto M, Koike K, Takeshita T.
    Pediatr Rheumatol Online J; 2019 Jul 03; 17(1):34. PubMed ID: 31269967
    [Abstract] [Full Text] [Related]

  • 4. HMGB1 gene polymorphism is associated with coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
    Ahn JG, Bae Y, Shin D, Nam J, Kim KY, Kim DS.
    Rheumatology (Oxford); 2019 May 01; 58(5):770-775. PubMed ID: 30535242
    [Abstract] [Full Text] [Related]

  • 5. Association of miR-146a Gene Polymorphism at loci rs2910164 G/C, rs57095329 A/G, and rs6864584 T/C with Susceptibility to Kawasaki Disease in Chinese Children.
    Zha L, Li S, Liu X, Li Z, Jiang J, Huang L, Yang Z.
    Pediatr Cardiol; 2019 Mar 01; 40(3):504-512. PubMed ID: 30291383
    [Abstract] [Full Text] [Related]

  • 6. The factors affecting the disease course in Kawasaki disease.
    Arslanoglu Aydin E, Ertugrul I, Bilginer Y, Batu ED, Sonmez HE, Demir S, Arici ZS, Sag E, Alehan D, Ozen S.
    Rheumatol Int; 2019 Aug 01; 39(8):1343-1349. PubMed ID: 31139951
    [Abstract] [Full Text] [Related]

  • 7. Higher efficacy of infliximab than immunoglobulin on Kawasaki disease, a meta-analysis.
    Li X, Tang Y, Ding Y, Chen Y, Hou M, Sun L, Qian G, Qin L, Lv H.
    Eur J Pharmacol; 2021 May 15; 899():173985. PubMed ID: 33652059
    [Abstract] [Full Text] [Related]

  • 8. IL-1B polymorphism in association with initial intravenous immunoglobulin treatment failure in Taiwanese children with Kawasaki disease.
    Weng KP, Hsieh KS, Ho TY, Huang SH, Lai CR, Chiu YT, Huang SC, Lin CC, Hwang YT, Ger LP.
    Circ J; 2010 Mar 15; 74(3):544-51. PubMed ID: 20081319
    [Abstract] [Full Text] [Related]

  • 9. Association of CCR2-CCR5 haplotypes and CCL3L1 copy number with Kawasaki Disease, coronary artery lesions, and IVIG responses in Japanese children.
    Mamtani M, Matsubara T, Shimizu C, Furukawa S, Akagi T, Onouchi Y, Hata A, Fujino A, He W, Ahuja SK, Burns JC.
    PLoS One; 2010 Jul 07; 5(7):e11458. PubMed ID: 20628649
    [Abstract] [Full Text] [Related]

  • 10. Assessment of risk factors for Korean children with Kawasaki disease.
    Kim JJ, Hong YM, Yun SW, Han MK, Lee KY, Song MS, Lee HD, Kim DS, Sohn S, Ha KS, Hong SJ, Kim KJ, Park IS, Jang GY, Lee JK, Korean Kawasaki Disease Genetics Consortium.
    Pediatr Cardiol; 2012 Apr 07; 33(4):513-20. PubMed ID: 22105492
    [Abstract] [Full Text] [Related]

  • 11. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
    Postgrad Med; 2018 May 07; 130(4):442-447. PubMed ID: 29745742
    [Abstract] [Full Text] [Related]

  • 12. Lack of CD4⁺CD25⁺FOXP3⁺ regulatory T cells is associated with resistance to intravenous immunoglobulin therapy in patients with Kawasaki disease.
    Hirabayashi Y, Takahashi Y, Xu Y, Akane K, Villalobos IB, Okuno Y, Hasegawa S, Muramatsu H, Hama A, Kato T, Kojima S.
    Eur J Pediatr; 2013 Jun 07; 172(6):833-7. PubMed ID: 23340699
    [Abstract] [Full Text] [Related]

  • 13. The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease.
    Chang LS, Lo MH, Li SC, Yang MY, Hsieh KS, Kuo HC.
    Oncotarget; 2017 Jan 10; 8(2):2044-2052. PubMed ID: 27893416
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
    Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y.
    Arthritis Rheum; 2013 Mar 10; 65(3):805-14. PubMed ID: 23440694
    [Abstract] [Full Text] [Related]

  • 15. Association of Genetic Polymorphisms in Kawasaki Disease with the Response to Intravenous Immunoglobulin Therapy.
    Sapountzi E, Fidani L, Giannopoulos A, Galli-Tsinopoulou A.
    Pediatr Cardiol; 2023 Jan 10; 44(1):1-12. PubMed ID: 35908117
    [Abstract] [Full Text] [Related]

  • 16. Japanese Kawasaki Disease Scoring Systems: Are they Applicable to the Iranian Population?
    Edraki MR, Mohammadi H, Mehdizadegan N, Ghorashi M, Amoozgar H, Borzouee M, Ajami G, Keshavarz K, Dehghani E, Bahrami R.
    Arch Iran Med; 2020 Jan 01; 23(1):31-36. PubMed ID: 31910632
    [Abstract] [Full Text] [Related]

  • 17. Association between maternal age and outcomes in Kawasaki disease patients.
    Huang WD, Lin YT, Tsai ZY, Chang LS, Liu SF, Lin YJ, Kuo HC.
    Pediatr Rheumatol Online J; 2019 Jul 19; 17(1):46. PubMed ID: 31324255
    [Abstract] [Full Text] [Related]

  • 18. Transcriptional regulation by infliximab therapy in Kawasaki disease patients with immunoglobulin resistance.
    Ogihara Y, Ogata S, Nomoto K, Ebato T, Sato K, Kokubo K, Kobayashi H, Ishii M.
    Pediatr Res; 2014 Sep 19; 76(3):287-93. PubMed ID: 24964229
    [Abstract] [Full Text] [Related]

  • 19. Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
    Wang JR, Zhao HZ, Chang LJ, Xu X, Gao Y, Li M, Kong QY, Wang MM, Zhao CF.
    Eur J Pediatr; 2023 Oct 19; 182(10):4399-4406. PubMed ID: 37480545
    [Abstract] [Full Text] [Related]

  • 20. Predictive model based on gene and laboratory data for intravenous immunoglobulin resistance in Kawasaki disease in a Chinese population.
    Meng L, Zhen Z, Jiang Q, Li XH, Yuan Y, Yao W, Zhang MM, Li AJ, Shi L.
    Pediatr Rheumatol Online J; 2021 Jun 26; 19(1):95. PubMed ID: 34174887
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.